Cargando…
Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204718/ https://www.ncbi.nlm.nih.gov/pubmed/35721301 http://dx.doi.org/10.1016/j.jdin.2022.05.001 |
| _version_ | 1784728986446725120 |
|---|---|
| author | Vender, Ronald Turchin, Irina Lansang, Perla Prajapati, Vimal H. Legault, Mark Barakat, Maxime Yeung, Jensen |
| author_facet | Vender, Ronald Turchin, Irina Lansang, Perla Prajapati, Vimal H. Legault, Mark Barakat, Maxime Yeung, Jensen |
| author_sort | Vender, Ronald |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9204718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92047182022-06-18 Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review Vender, Ronald Turchin, Irina Lansang, Perla Prajapati, Vimal H. Legault, Mark Barakat, Maxime Yeung, Jensen JAAD Int Research Letter Elsevier 2022-06-13 /pmc/articles/PMC9204718/ /pubmed/35721301 http://dx.doi.org/10.1016/j.jdin.2022.05.001 Text en © 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Research Letter Vender, Ronald Turchin, Irina Lansang, Perla Prajapati, Vimal H. Legault, Mark Barakat, Maxime Yeung, Jensen Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_full | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_fullStr | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_full_unstemmed | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_short | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_sort | real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: a canadian multicenter retrospective chart review |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204718/ https://www.ncbi.nlm.nih.gov/pubmed/35721301 http://dx.doi.org/10.1016/j.jdin.2022.05.001 |
| work_keys_str_mv | AT venderronald realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT turchinirina realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT lansangperla realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT prajapativimalh realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT legaultmark realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT barakatmaxime realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT yeungjensen realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview |